248 related articles for article (PubMed ID: 35969834)
61. Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease.
Adam B; Koldehoff M; Ditschkowski M; Gromke T; Hlinka M; Trenschel R; Kordeals L; Steckel NK; Beelen DW; Liebregts T
Dig Dis Sci; 2016 Jul; 61(7):2019-26. PubMed ID: 26995779
[TBL] [Abstract][Full Text] [Related]
62. Prolonged gut microbial alterations in post-transplant survivors of allogeneic haematopoietic stem cell transplantation.
Hino A; Fukushima K; Kusakabe S; Ueda T; Sudo T; Fujita J; Motooka D; Takeda AK; Shinozaki NO; Watanabe S; Yokota T; Shibayama H; Nakamura S; Hosen N
Br J Haematol; 2023 May; 201(4):725-737. PubMed ID: 36468273
[TBL] [Abstract][Full Text] [Related]
63. Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD.
Köhler N; Zeiser R
Front Immunol; 2018; 9():3179. PubMed ID: 30705680
[TBL] [Abstract][Full Text] [Related]
64. Update in clinical and mouse microbiota research in allogeneic haematopoietic cell transplantation.
Lindner S; Peled JU
Curr Opin Hematol; 2020 Nov; 27(6):360-367. PubMed ID: 33003084
[TBL] [Abstract][Full Text] [Related]
65. Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients.
van Lier YF; Davids M; Haverkate NJE; de Groot PF; Donker ML; Meijer E; Heubel-Moenen FCJI; Nur E; Zeerleder SS; Nieuwdorp M; Blom B; Hazenberg MD
Sci Transl Med; 2020 Aug; 12(556):. PubMed ID: 32801142
[TBL] [Abstract][Full Text] [Related]
66. Longitudinal dynamics of gut microbiota in the pathogenesis of acute graft-versus-host disease.
Qi L; Peng J; Huang X; Zhou T; Tan G; Li F
Cancer Med; 2023 Dec; 12(24):21567-21578. PubMed ID: 38053512
[TBL] [Abstract][Full Text] [Related]
67. GPR Expression in Intestinal Biopsies From SCT Patients Is Upregulated in GvHD and Is Suppressed by Broad-Spectrum Antibiotics.
Ghimire S; Weber D; Hippe K; Meedt E; Hoepting M; Kattner AS; Hiergeist A; Gessner A; Matos C; Ghimire S; Wolff D; Edinger M; Hoffmann P; Poeck H; Herr W; Holler E
Front Immunol; 2021; 12():753287. PubMed ID: 34777363
[TBL] [Abstract][Full Text] [Related]
68. Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation.
Khuat LT; Le CT; Pai CS; Shields-Cutler RR; Holtan SG; Rashidi A; Parker SL; Knights D; Luna JI; Dunai C; Wang Z; Sturgill IR; Stoffel KM; Merleev AA; More SK; Maverakis E; Raybould HE; Chen M; Canter RJ; Monjazeb AM; Dave M; Ferrara JLM; Levine JE; Longo DL; Abedi M; Blazar BR; Murphy WJ
Sci Transl Med; 2020 Nov; 12(571):. PubMed ID: 33239390
[TBL] [Abstract][Full Text] [Related]
69. Microbiome-intestine cross talk during acute graft-versus-host disease.
Rafei H; Jenq RR
Blood; 2020 Jul; 136(4):401-409. PubMed ID: 32526029
[TBL] [Abstract][Full Text] [Related]
70. Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States.
McGuirk J; Divine C; Moon SH; Chandak A; Zhang Z; Papanicolaou GA
Transplant Cell Ther; 2021 Jun; 27(6):505.e1-505.e9. PubMed ID: 33775616
[TBL] [Abstract][Full Text] [Related]
71. Incidence and Outcomes of Bacterial Bloodstream Infections during Acute Graft-versus-Host Disease Involving the Gastrointestinal Tract after Hematopoietic Cell Transplantation.
Petersen J; Lindner C; Hakki M
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1648-1653. PubMed ID: 31002988
[TBL] [Abstract][Full Text] [Related]
72. Vedolizumab in highly resistant acute gastrointestinal graft-versus-host disease after allogeneic stem cell transplantation: A single-center pediatric series.
Rosa M; Jarmoliński T; Miśkiewicz-Migoń I; Liszka K; Miśkiewicz-Bujna J; Panasiuk A; Frączkiewicz J; Ussowicz M
Adv Clin Exp Med; 2022 Mar; 31(3):345-350. PubMed ID: 35212198
[TBL] [Abstract][Full Text] [Related]
73. Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Omer AK; Weisdorf DJ; Lazaryan A; Shanley R; Blazar BR; MacMillan ML; Brunstein C; Bejanyan N; Arora M
Biol Blood Marrow Transplant; 2016 May; 22(5):879-83. PubMed ID: 26743342
[TBL] [Abstract][Full Text] [Related]
74. Steroid-Sensitive, but Not Steroid-Dependent or Steroid-Resistant Acute Graft-versus-Host Disease, Results in Similar Infection Risk as No Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation.
Young JH; El Jurdi N; Rayes A; MacMillan ML; Holtan SG; Cao Q; Witte J; Arora M; Weisdorf DJ
Transplant Cell Ther; 2022 Aug; 28(8):509.e1-509.e11. PubMed ID: 35577324
[TBL] [Abstract][Full Text] [Related]
75. The association between the incidence of intestinal graft-vs-host disease and antibiotic use after allogeneic hematopoietic stem cell transplantation.
Hidaka D; Hayase E; Shiratori S; Hasegawa Y; Ishio T; Tateno T; Okada K; Goto H; Sugita J; Onozawa M; Nakagawa M; Kahata K; Endo T; Hashimoto D; Teshima T
Clin Transplant; 2018 Sep; 32(9):e13361. PubMed ID: 30054935
[TBL] [Abstract][Full Text] [Related]
76. Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial.
Zhao Y; Li X; Zhou Y; Gao J; Jiao Y; Zhu B; Wu D; Qi X
Front Immunol; 2021; 12():678476. PubMed ID: 34220825
[TBL] [Abstract][Full Text] [Related]
77. A gut microbiota score predicting acute graft-versus-host disease following myeloablative allogeneic hematopoietic stem cell transplantation.
Han L; Zhao K; Li Y; Han H; Zhou L; Ma P; Fan Z; Sun H; Jin H; Jiang Z; Liu Q; Peng J
Am J Transplant; 2020 Apr; 20(4):1014-1027. PubMed ID: 31605563
[TBL] [Abstract][Full Text] [Related]
78. The Role of Intestinal Microbiota in Acute Graft-versus-Host Disease.
Chen Y; Zhao Y; Cheng Q; Wu D; Liu H
J Immunol Res; 2015; 2015():145859. PubMed ID: 26090477
[TBL] [Abstract][Full Text] [Related]
79. Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children.
Masetti R; Leardini D; Muratore E; Fabbrini M; D'Amico F; Zama D; Baccelli F; Gottardi F; Belotti T; Ussowicz M; Fraczkiewicz J; Cesaro S; Zecca M; Merli P; Candela M; Pession A; Locatelli F; Prete A; Brigidi P; Turroni S
Blood; 2023 Oct; 142(16):1387-1398. PubMed ID: 37856089
[TBL] [Abstract][Full Text] [Related]
80. Allogenic stem cell transplant-associated acute graft versus host disease: a computational drug discovery text mining approach using oral and gut microbiome signatures.
Beckman MF; Morton DS; Bahrani Mougeot F; Mougeot JC
Support Care Cancer; 2021 Apr; 29(4):1765-1779. PubMed ID: 33094358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
